From selling laddoos on a cart to running a multi-crore empire, Pramod’s journey exemplifies the power of perseverance and ...

In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...

Imagine taking a borrowed $100 and transforming it into a multibillion-dollar fortune. That’s not the plot of a Hollywood ...

Rakesh Jhunjhunwala's journey from $100 to $5.8 billion is a great example in financial history which shows the fact that ...

The fund’s strategy, top holdings, and recent portfolio moves are explored to provide insights for existing and potential ...

The fund’s strategy, top holdings, and recent portfolio moves are explored to provide insights for existing and potential ...

Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 98,280.64 Crore) operating in Pharmaceuticals sector. Lupin Ltd. key Products/Revenue Segments include ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...

GTPL Hathway profits tanked 57% at ₹10.2 crore against ₹23.7 crore. However, its revenue was seen increasing by 4.3% to ₹887.3 crore from ₹850.9 crore.